BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lasfar A, Zloza A, de la Torre A, Cohen-Solal KA. IFN-λ: A New Inducer of Local Immunity against Cancer and Infections. Front Immunol 2016;7:598. [PMID: 28018361 DOI: 10.3389/fimmu.2016.00598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi H, Yu F, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Xu R, Jiang M, Shi J. EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma. J Thorac Dis 2018;10:2779-88. [PMID: 29997940 DOI: 10.21037/jtd.2018.04.91] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kumar NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, Nancy A, Jeyadeepa B, Selvaraj N, Ashokan D, Renji RM, Venkataramani V, Tripathy S, Babu S. BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals. Int J Infect Dis 2021;110:98-104. [PMID: 34302964 DOI: 10.1016/j.ijid.2021.07.041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Cannella F, Scagnolari C, Statzu M, Sciandra I, Recine N, d'Ettorre G, Antonelli G, Pierangeli A. Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome. Virus Genes 2018;54:319-22. [PMID: 29243064 DOI: 10.1007/s11262-017-1527-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Maddaluno L, Urwyler C, Rauschendorfer T, Meyer M, Stefanova D, Spörri R, Wietecha M, Ferrarese L, Stoycheva D, Bender D, Li N, Strittmatter G, Nasirujjaman K, Beer HD, Staeheli P, Hildt E, Oxenius A, Werner S. Antagonism of interferon signaling by fibroblast growth factors promotes viral replication. EMBO Mol Med 2020;12:e11793. [PMID: 32720440 DOI: 10.15252/emmm.201911793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Hou W, Qiao K, Huo Z, Du Y, Wang C, Syn WK. Association of IFNL3 rs12979860 polymorphism with HCV-related hepatocellular carcinoma susceptibility in a Chinese population. Clin Exp Gastroenterol 2019;12:433-9. [PMID: 31807049 DOI: 10.2147/CEG.S206194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Rajamanickam A, Munisankar S, Bhootra Y, Dolla C, Nutman TB, Babu S. Elevated Systemic and Parasite-Antigen Stimulated Levels of Type III IFNs in a Chronic Helminth Infection and Reversal Following Anthelmintic Treatment. Front Immunol 2018;9:2353. [PMID: 30405603 DOI: 10.3389/fimmu.2018.02353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Lasfar A, Zloza A, Silk AW, Lee LY, Cohen-solal KA. Interferon Lambda: Toward a Dual Role in Cancer. Journal of Interferon & Cytokine Research 2019;39:22-9. [DOI: 10.1089/jir.2018.0046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
8 Li Z, Peng A, Feng Y, Zhang X, Liu F, Chen C, Ye X, Qu J, Jin C, Wang M, Qiu H, Qi Y, Huang J, Yang Q. Detection of T lymphocyte subsets and related functional molecules in follicular fluid of patients with polycystic ovary syndrome. Sci Rep 2019;9:6040. [PMID: 30988342 DOI: 10.1038/s41598-019-42631-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Choobin H, Bamdad T, Shekarabi M. The pattern of antiviral protein expression induced by interferon λ1 in peripheral blood mononuclear cells of patients with chronic hepatitis C virus infection. Arch Virol 2020;165:583-92. [PMID: 31927635 DOI: 10.1007/s00705-019-04438-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Abdolvahab MH, Darvishi B, Zarei M, Majidzadeh-A K, Farahmand L. Interferons: role in cancer therapy. Immunotherapy 2020;12:833-55. [PMID: 32635782 DOI: 10.2217/imt-2019-0217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Bou-Hanna C, Jarry A, Mosnier JF, Bossard C, Laboisse CL. The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells. Oncotarget 2018;9:34471-84. [PMID: 30349642 DOI: 10.18632/oncotarget.26121] [Reference Citation Analysis]
12 Zhao H, Dong N, Liu T, Zhang P, Zheng Y, Yang L, Ren X. Clinical Significance of Serum Type III Interferons in Patients with Gastric Cancer. J Interferon Cytokine Res 2019;39:155-63. [PMID: 30672717 DOI: 10.1089/jir.2018.0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Zhang Z, Filzmayer C, Ni Y, Sültmann H, Mutz P, Hiet MS, Vondran FWR, Bartenschlager R, Urban S. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes. J Hepatol 2018;69:25-35. [PMID: 29524530 DOI: 10.1016/j.jhep.2018.02.021] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]